“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a reality,” said Stephen Saad, Aspen Group Chief Executive.
“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a reality,” said Stephen Saad, Aspen Group Chief Executive.
南非德班 – 作为南非证券交易所上市的跨国专业制药公司，爱施健制药公司 (Aspen Pharmacare Holdings Limited，APN) 日前宣布其全资南非子公司Aspen SA Operations (Pty) Limited（Aspen SA Operations）与强生集团旗下的杨森制药公司Janssen Pharmaceuticals, Inc.达成协议，面向非洲地区生产和供应爱施健集团品牌新冠疫苗“Aspenovax”[1]。
